The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Subcutaneous Allergy Immunotherapies Market Research Report 2025
Synopsis
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The global Subcutaneous Allergy Immunotherapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Allergy Immunotherapies.
Report Scope
The Subcutaneous Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Allergy Immunotherapies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Segment by Type
High Concentration
Low Concentration
Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Allergy Immunotherapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The global Subcutaneous Allergy Immunotherapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Allergy Immunotherapies.
Report Scope
The Subcutaneous Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Allergy Immunotherapies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Segment by Type
High Concentration
Low Concentration
Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Allergy Immunotherapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Subcutaneous Allergy Immunotherapies Market Overview
1.1 Product Overview and Scope of Subcutaneous Allergy Immunotherapies
1.2 Subcutaneous Allergy Immunotherapies Segment by Type
1.2.1 Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2024-2030)
1.2.2 High Concentration
1.2.3 Low Concentration
1.3 Subcutaneous Allergy Immunotherapies Segment by Application
1.3.1 Global Subcutaneous Allergy Immunotherapies Market Value by Application: (2024-2030)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Allergy Immunotherapies Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Allergy Immunotherapies Revenue 2019-2030
1.4.2 Global Subcutaneous Allergy Immunotherapies Sales 2019-2030
1.4.3 Global Subcutaneous Allergy Immunotherapies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Subcutaneous Allergy Immunotherapies Market Competition by Manufacturers
2.1 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers (2019-2024)
2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Subcutaneous Allergy Immunotherapies Average Price by Manufacturers (2019-2024)
2.4 Global Subcutaneous Allergy Immunotherapies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Product Type & Application
2.7 Subcutaneous Allergy Immunotherapies Market Competitive Situation and Trends
2.7.1 Subcutaneous Allergy Immunotherapies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Subcutaneous Allergy Immunotherapies Players Market Share by Revenue
2.7.3 Global Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Allergy Immunotherapies Retrospective Market Scenario by Region
3.1 Global Subcutaneous Allergy Immunotherapies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Subcutaneous Allergy Immunotherapies Global Subcutaneous Allergy Immunotherapies Sales by Region: 2019-2030
3.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2019-2024
3.2.2 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2025-2030
3.3 Global Subcutaneous Allergy Immunotherapies Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2019-2030
3.3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2019-2024
3.3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2025-2030
3.4 North America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.4.1 North America Subcutaneous Allergy Immunotherapies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Subcutaneous Allergy Immunotherapies Sales by Country (2019-2030)
3.4.3 North America Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Allergy Immunotherapies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2019-2030)
3.5.3 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.6.1 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2019-2030)
3.6.3 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Allergy Immunotherapies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2019-2030)
3.7.3 Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2019-2030)
3.8.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2019-2030)
4.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2019-2024)
4.1.2 Global Subcutaneous Allergy Immunotherapies Sales by Type (2025-2030)
4.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2019-2030)
4.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2019-2030)
4.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2019-2024)
4.2.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2025-2030)
4.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2019-2030)
4.3 Global Subcutaneous Allergy Immunotherapies Price by Type (2019-2030)
5 Segment by Application
5.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2019-2030)
5.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2019-2024)
5.1.2 Global Subcutaneous Allergy Immunotherapies Sales by Application (2025-2030)
5.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2019-2030)
5.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2019-2030)
5.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2019-2024)
5.2.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2025-2030)
5.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2019-2030)
5.3 Global Subcutaneous Allergy Immunotherapies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ALK-Abello
6.1.1 ALK-Abello Corporation Information
6.1.2 ALK-Abello Description and Business Overview
6.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio
6.1.5 ALK-Abello Recent Developments/Updates
6.2 Stallergenes Greer
6.2.1 Stallergenes Greer Corporation Information
6.2.2 Stallergenes Greer Description and Business Overview
6.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio
6.2.5 Stallergenes Greer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Subcutaneous Allergy Immunotherapies Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Corporation Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 HAL
6.5.1 HAL Corporation Information
6.5.2 HAL Description and Business Overview
6.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HAL Subcutaneous Allergy Immunotherapies Product Portfolio
6.5.5 HAL Recent Developments/Updates
6.6 WOLW Pharma
6.6.1 WOLW Pharma Corporation Information
6.6.2 WOLW Pharma Description and Business Overview
6.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio
6.6.5 WOLW Pharma Recent Developments/Updates
6.7 Holister Stier
6.6.1 Holister Stier Corporation Information
6.6.2 Holister Stier Description and Business Overview
6.6.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio
6.7.5 Holister Stier Recent Developments/Updates
6.8 Leti
6.8.1 Leti Corporation Information
6.8.2 Leti Description and Business Overview
6.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Leti Subcutaneous Allergy Immunotherapies Product Portfolio
6.8.5 Leti Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Allergy Immunotherapies Industry Chain Analysis
7.2 Subcutaneous Allergy Immunotherapies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Allergy Immunotherapies Production Mode & Process
7.4 Subcutaneous Allergy Immunotherapies Sales and Marketing
7.4.1 Subcutaneous Allergy Immunotherapies Sales Channels
7.4.2 Subcutaneous Allergy Immunotherapies Distributors
7.5 Subcutaneous Allergy Immunotherapies Customers
8 Subcutaneous Allergy Immunotherapies Market Dynamics
8.1 Subcutaneous Allergy Immunotherapies Industry Trends
8.2 Subcutaneous Allergy Immunotherapies Market Drivers
8.3 Subcutaneous Allergy Immunotherapies Market Challenges
8.4 Subcutaneous Allergy Immunotherapies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Subcutaneous Allergy Immunotherapies Market Competitive Situation by Manufacturers in 2023
Table 4. Global Subcutaneous Allergy Immunotherapies Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Subcutaneous Allergy Immunotherapies Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Subcutaneous Allergy Immunotherapies Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Subcutaneous Allergy Immunotherapies, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Product Type & Application
Table 12. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Subcutaneous Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Allergy Immunotherapies as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Subcutaneous Allergy Immunotherapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Subcutaneous Allergy Immunotherapies Sales by Region (2019-2024) & (K Units)
Table 18. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2019-2024)
Table 19. Global Subcutaneous Allergy Immunotherapies Sales by Region (2025-2030) & (K Units)
Table 20. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2025-2030)
Table 21. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2019-2024)
Table 23. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2025-2030)
Table 25. North America Subcutaneous Allergy Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Subcutaneous Allergy Immunotherapies Sales by Country (2019-2024) & (K Units)
Table 27. North America Subcutaneous Allergy Immunotherapies Sales by Country (2025-2030) & (K Units)
Table 28. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Subcutaneous Allergy Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2019-2024) & (K Units)
Table 32. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2025-2030) & (K Units)
Table 33. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Type (2019-2024)
Table 51. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Type (2025-2030)
Table 52. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2019-2024)
Table 53. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2025-2030)
Table 54. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2019-2024)
Table 57. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2025-2030)
Table 58. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2019-2024)
Table 59. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2025-2030)
Table 60. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Application (2019-2024)
Table 61. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Application (2025-2030)
Table 62. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2019-2024)
Table 63. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2025-2030)
Table 64. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2019-2024)
Table 67. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2025-2030)
Table 68. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2019-2024)
Table 69. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2025-2030)
Table 70. ALK-Abello Corporation Information
Table 71. ALK-Abello Description and Business Overview
Table 72. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. ALK-Abello Subcutaneous Allergy Immunotherapies Product
Table 74. ALK-Abello Recent Developments/Updates
Table 75. Stallergenes Greer Corporation Information
Table 76. Stallergenes Greer Description and Business Overview
Table 77. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product
Table 79. Stallergenes Greer Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Subcutaneous Allergy Immunotherapies Product
Table 84. Merck Recent Developments/Updates
Table 85. Allergy Therapeutics Corporation Information
Table 86. Allergy Therapeutics Description and Business Overview
Table 87. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product
Table 89. Allergy Therapeutics Recent Developments/Updates
Table 90. HAL Corporation Information
Table 91. HAL Description and Business Overview
Table 92. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. HAL Subcutaneous Allergy Immunotherapies Product
Table 94. HAL Recent Developments/Updates
Table 95. WOLW Pharma Corporation Information
Table 96. WOLW Pharma Description and Business Overview
Table 97. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. WOLW Pharma Subcutaneous Allergy Immunotherapies Product
Table 99. WOLW Pharma Recent Developments/Updates
Table 100. Holister Stier Corporation Information
Table 101. Holister Stier Description and Business Overview
Table 102. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Holister Stier Subcutaneous Allergy Immunotherapies Product
Table 104. Holister Stier Recent Developments/Updates
Table 105. Leti Corporation Information
Table 106. Leti Description and Business Overview
Table 107. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Leti Subcutaneous Allergy Immunotherapies Product
Table 109. Leti Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Subcutaneous Allergy Immunotherapies Distributors List
Table 113. Subcutaneous Allergy Immunotherapies Customers List
Table 114. Subcutaneous Allergy Immunotherapies Market Trends
Table 115. Subcutaneous Allergy Immunotherapies Market Drivers
Table 116. Subcutaneous Allergy Immunotherapies Market Challenges
Table 117. Subcutaneous Allergy Immunotherapies Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Subcutaneous Allergy Immunotherapies
Figure 2. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Subcutaneous Allergy Immunotherapies Market Share by Type in 2023 & 2030
Figure 4. High Concentration Product Picture
Figure 5. Low Concentration Product Picture
Figure 6. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Subcutaneous Allergy Immunotherapies Market Share by Application in 2023 & 2030
Figure 8. Primary Immunodeficiency
Figure 9. Secondary Immunodeficiency
Figure 10. Others
Figure 11. Global Subcutaneous Allergy Immunotherapies Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Subcutaneous Allergy Immunotherapies Market Size (2019-2030) & (US$ Million)
Figure 13. Global Subcutaneous Allergy Immunotherapies Sales (2019-2030) & (K Units)
Figure 14. Global Subcutaneous Allergy Immunotherapies Average Price (US$/Unit) & (2019-2030)
Figure 15. Subcutaneous Allergy Immunotherapies Report Years Considered
Figure 16. Subcutaneous Allergy Immunotherapies Sales Share by Manufacturers in 2023
Figure 17. Global Subcutaneous Allergy Immunotherapies Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Subcutaneous Allergy Immunotherapies Players: Market Share by Revenue in 2023
Figure 19. Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Subcutaneous Allergy Immunotherapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2019-2030)
Figure 22. North America Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2019-2030)
Figure 23. United States Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2019-2030)
Figure 26. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2019-2030)
Figure 27. Germany Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2019-2030)
Figure 34. China Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2019-2030)
Figure 44. Latin America Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Subcutaneous Allergy Immunotherapies by Type (2019-2030)
Figure 54. Global Revenue Market Share of Subcutaneous Allergy Immunotherapies by Type (2019-2030)
Figure 55. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Subcutaneous Allergy Immunotherapies by Application (2019-2030)
Figure 57. Global Revenue Market Share of Subcutaneous Allergy Immunotherapies by Application (2019-2030)
Figure 58. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2019-2030)
Figure 59. Subcutaneous Allergy Immunotherapies Value Chain
Figure 60. Subcutaneous Allergy Immunotherapies Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
